Table 1.
Demographic, clinical and blood pressure data in the whole study population
| Minimental state evaluation score | ||
|---|---|---|
| 0‐23 | 24‐30 | |
| N | 26 | 445 |
| Age (years) | 64 (58‐69) | 63 (59‐69) |
| Body mass index (kg/m2) | 26.5 (23.7‐30.9) | 26.3 (23.8‐29.0) |
| Smoking (%) | 15.4 | 18.2 |
| Male (%) | 50.0 | 53.0 |
| Hypertensive drug (%) | 42.3 | 30.8 |
| Office SBP (mm Hg) | 145 (130‐162) | 140 (130‐156) |
| Office DBP (mm Hg) | 86 (84‐90) | 88 (80‐94) |
| Office HR (beat/min) | 68 (64‐76) | 68 (64‐76) |
| 24 h SBP (mm Hg) | 124 (118‐133) | 123 (115‐132) |
| 24 h DBP (mm Hg) | 77 (72‐80) | 75 (71‐81) |
| 24 h HR (beat/min) | 77 (70‐79) | 73 (68‐79) |
| Home SBP (mm Hg) | 140 (134‐150) | 132 (121‐146) |
| Home DBP (mm Hg) | 78 (71‐92) | 79 (73‐86) |
| Home HR (beat/min) | 69 (64‐75) | 71 (65‐77) |
| Residual variability SBP* | 11.5 (9.4‐12.9) | 10.1 (8.8‐11.8) |
| Residual variability DBP* | 9.5 (7.8‐10.9) | 8.3 (7‐9.9) |
| SD 24 h SBP | 15.1 (12.6‐17.3) | 14.4 (12.0‐17.2) |
| SD 24 h DBP | 13.1 (10.8‐15.4) | 12.1 (9.9‐14.3) |
| Male (n) | 13 | 236 |
| Residual variability SBP | 11.1 (10.2‐13.1) | 10.1 (8.7‐12.0) |
| Residual variability DBP | 9.1 (8.0‐10.3) | 8.4 (7.0‐9.7) |
| Female (n) | 13 | 209 |
| Residual variability SBP | 11.7 (9.4‐12.4) | 9.9 (8.9‐11.6) |
| Residual variability DBP | 9.9 (7.8‐11.2) | 8.3 (7.0‐10.3) |
Data are shown as median (IQR) or %.
DBP: diastolic blood pressure, HR: heart rate, SBP: systolic blood pressure, SD: standard deviation.
*
P < 0.05.